nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—CA3—Reversible hydration of carbon dioxide—CA7—colon cancer	0.114	0.196	CbGpPWpGaD
Lacosamide—CA14—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0736	0.126	CbGpPWpGaD
Lacosamide—CA6—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0717	0.123	CbGpPWpGaD
Lacosamide—CA5B—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0669	0.115	CbGpPWpGaD
Lacosamide—CA4—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0494	0.0849	CbGpPWpGaD
Lacosamide—CA2—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0474	0.0814	CbGpPWpGaD
Lacosamide—CA1—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0454	0.078	CbGpPWpGaD
Lacosamide—CA9—Reversible hydration of carbon dioxide—CA7—colon cancer	0.04	0.0686	CbGpPWpGaD
Lacosamide—Cerebellar syndrome—Fluorouracil—colon cancer	0.0162	0.052	CcSEcCtD
Lacosamide—CA9—gall bladder—colon cancer	0.012	0.114	CbGeAlD
Lacosamide—Hypoaesthesia oral—Capecitabine—colon cancer	0.00871	0.028	CcSEcCtD
Lacosamide—Balance disorder—Fluorouracil—colon cancer	0.00595	0.0191	CcSEcCtD
Lacosamide—Drug hypersensitivity—Capecitabine—colon cancer	0.00564	0.0181	CcSEcCtD
Lacosamide—Depressed mood—Capecitabine—colon cancer	0.00508	0.0163	CcSEcCtD
Lacosamide—Nystagmus—Vincristine—colon cancer	0.00488	0.0157	CcSEcCtD
Lacosamide—Paraesthesia oral—Capecitabine—colon cancer	0.00485	0.0156	CcSEcCtD
Lacosamide—CA9—digestive system—colon cancer	0.00474	0.0448	CbGeAlD
Lacosamide—CA2—gall bladder—colon cancer	0.00457	0.0432	CbGeAlD
Lacosamide—CA3—bone marrow—colon cancer	0.00456	0.0431	CbGeAlD
Lacosamide—Nystagmus—Fluorouracil—colon cancer	0.00456	0.0146	CcSEcCtD
Lacosamide—CA3—vagina—colon cancer	0.00437	0.0413	CbGeAlD
Lacosamide—Balance disorder—Capecitabine—colon cancer	0.00416	0.0133	CcSEcCtD
Lacosamide—Cognitive disorder—Methotrexate—colon cancer	0.00391	0.0126	CcSEcCtD
Lacosamide—SCN3A—renal system—colon cancer	0.00373	0.0352	CbGeAlD
Lacosamide—CA3—liver—colon cancer	0.00369	0.0349	CbGeAlD
Lacosamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—colon cancer	0.00367	0.00629	CbGpPWpGaD
Lacosamide—Dysarthria—Irinotecan—colon cancer	0.00359	0.0115	CcSEcCtD
Lacosamide—Gait disturbance—Vincristine—colon cancer	0.00357	0.0115	CcSEcCtD
Lacosamide—Gait disturbance—Irinotecan—colon cancer	0.00348	0.0112	CcSEcCtD
Lacosamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—colon cancer	0.00347	0.00596	CbGpPWpGaD
Lacosamide—Dysarthria—Fluorouracil—colon cancer	0.00344	0.011	CcSEcCtD
Lacosamide—SCN10A—lymphoid tissue—colon cancer	0.00339	0.0321	CbGeAlD
Lacosamide—CA1—renal system—colon cancer	0.00339	0.032	CbGeAlD
Lacosamide—CA14—liver—colon cancer	0.00335	0.0317	CbGeAlD
Lacosamide—CA2—embryo—colon cancer	0.0029	0.0274	CbGeAlD
Lacosamide—Memory impairment—Capecitabine—colon cancer	0.0029	0.0093	CcSEcCtD
Lacosamide—CA3—lymph node—colon cancer	0.00283	0.0267	CbGeAlD
Lacosamide—SCN3A—bone marrow—colon cancer	0.00282	0.0266	CbGeAlD
Lacosamide—CA1—lymphoid tissue—colon cancer	0.00281	0.0266	CbGeAlD
Lacosamide—Euphoric mood—Fluorouracil—colon cancer	0.0028	0.00897	CcSEcCtD
Lacosamide—Injection site pain—Capecitabine—colon cancer	0.00278	0.00894	CcSEcCtD
Lacosamide—CA1—digestive system—colon cancer	0.00278	0.0263	CbGeAlD
Lacosamide—CA5B—vagina—colon cancer	0.00278	0.0263	CbGeAlD
Lacosamide—SCN3A—vagina—colon cancer	0.0027	0.0255	CbGeAlD
Lacosamide—CA4—renal system—colon cancer	0.00265	0.025	CbGeAlD
Lacosamide—CA9—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.00262	0.0045	CbGpPWpGaD
Lacosamide—Contusion—Capecitabine—colon cancer	0.00261	0.00836	CcSEcCtD
Lacosamide—Proteinuria—Capecitabine—colon cancer	0.00259	0.0083	CcSEcCtD
Lacosamide—CA1—bone marrow—colon cancer	0.00256	0.0242	CbGeAlD
Lacosamide—Protein urine present—Capecitabine—colon cancer	0.00255	0.00819	CcSEcCtD
Lacosamide—SCN9A—lymph node—colon cancer	0.00252	0.0238	CbGeAlD
Lacosamide—Osteoarthritis—Irinotecan—colon cancer	0.00247	0.00791	CcSEcCtD
Lacosamide—Dysarthria—Capecitabine—colon cancer	0.0024	0.00771	CcSEcCtD
Lacosamide—Ataxia—Vincristine—colon cancer	0.00238	0.00764	CcSEcCtD
Lacosamide—CA2—epithelium—colon cancer	0.00237	0.0224	CbGeAlD
Lacosamide—Osteoarthritis—Fluorouracil—colon cancer	0.00236	0.00758	CcSEcCtD
Lacosamide—Gait disturbance—Capecitabine—colon cancer	0.00233	0.00747	CcSEcCtD
Lacosamide—CA3—Metabolism—CA7—colon cancer	0.00232	0.00398	CbGpPWpGaD
Lacosamide—Coordination abnormal—Capecitabine—colon cancer	0.00232	0.00743	CcSEcCtD
Lacosamide—CA2—smooth muscle tissue—colon cancer	0.00228	0.0216	CbGeAlD
Lacosamide—Irritability—Fluorouracil—colon cancer	0.00225	0.00723	CcSEcCtD
Lacosamide—Ataxia—Fluorouracil—colon cancer	0.00222	0.00713	CcSEcCtD
Lacosamide—CA2—renal system—colon cancer	0.00219	0.0207	CbGeAlD
Lacosamide—CA4—digestive system—colon cancer	0.00217	0.0205	CbGeAlD
Lacosamide—CA1—liver—colon cancer	0.00207	0.0196	CbGeAlD
Lacosamide—Neutropenia—Vincristine—colon cancer	0.00205	0.00657	CcSEcCtD
Lacosamide—Eosinophilia—Fluorouracil—colon cancer	0.00202	0.00649	CcSEcCtD
Lacosamide—CA4—bone marrow—colon cancer	0.002	0.0189	CbGeAlD
Lacosamide—Neutropenia—Irinotecan—colon cancer	0.00199	0.0064	CcSEcCtD
Lacosamide—Depression—Vincristine—colon cancer	0.00195	0.00624	CcSEcCtD
Lacosamide—Proteinuria—Methotrexate—colon cancer	0.00193	0.00618	CcSEcCtD
Lacosamide—SCN10A—lymph node—colon cancer	0.00191	0.0181	CbGeAlD
Lacosamide—Protein urine present—Methotrexate—colon cancer	0.0019	0.0061	CcSEcCtD
Lacosamide—CA2—lymphoid tissue—colon cancer	0.00182	0.0172	CbGeAlD
Lacosamide—CA2—digestive system—colon cancer	0.0018	0.017	CbGeAlD
Lacosamide—CA5B—lymph node—colon cancer	0.0018	0.017	CbGeAlD
Lacosamide—Dysarthria—Methotrexate—colon cancer	0.00179	0.00574	CcSEcCtD
Lacosamide—SCN3A—lymph node—colon cancer	0.00175	0.0165	CbGeAlD
Lacosamide—Hallucination—Vincristine—colon cancer	0.00174	0.00559	CcSEcCtD
Lacosamide—Hypoaesthesia—Vincristine—colon cancer	0.00174	0.00559	CcSEcCtD
Lacosamide—Atrial fibrillation—Capecitabine—colon cancer	0.00174	0.00559	CcSEcCtD
Lacosamide—Bradycardia—Irinotecan—colon cancer	0.00174	0.00557	CcSEcCtD
Lacosamide—Connective tissue disorder—Vincristine—colon cancer	0.00172	0.00552	CcSEcCtD
Lacosamide—Agranulocytosis—Fluorouracil—colon cancer	0.0017	0.00545	CcSEcCtD
Lacosamide—Connective tissue disorder—Irinotecan—colon cancer	0.00168	0.00538	CcSEcCtD
Lacosamide—CA2—bone marrow—colon cancer	0.00166	0.0157	CbGeAlD
Lacosamide—Osteoarthritis—Capecitabine—colon cancer	0.00165	0.0053	CcSEcCtD
Lacosamide—Diplopia—Capecitabine—colon cancer	0.00165	0.0053	CcSEcCtD
Lacosamide—CA9—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.00164	0.00281	CbGpPWpGaD
Lacosamide—Cardiac disorder—Vincristine—colon cancer	0.00163	0.00522	CcSEcCtD
Lacosamide—Hypoaesthesia—Fluorouracil—colon cancer	0.00163	0.00522	CcSEcCtD
Lacosamide—CA9—Cellular response to hypoxia—EP300—colon cancer	0.00162	0.00278	CbGpPWpGaD
Lacosamide—CA2—vagina—colon cancer	0.00159	0.015	CbGeAlD
Lacosamide—CA1—lymph node—colon cancer	0.00159	0.015	CbGeAlD
Lacosamide—Cardiac disorder—Irinotecan—colon cancer	0.00158	0.00508	CcSEcCtD
Lacosamide—Irritability—Capecitabine—colon cancer	0.00158	0.00505	CcSEcCtD
Lacosamide—Mood swings—Capecitabine—colon cancer	0.00156	0.00502	CcSEcCtD
Lacosamide—Ataxia—Capecitabine—colon cancer	0.00155	0.00498	CcSEcCtD
Lacosamide—Immune system disorder—Irinotecan—colon cancer	0.00154	0.00494	CcSEcCtD
Lacosamide—Mental disorder—Vincristine—colon cancer	0.00153	0.00492	CcSEcCtD
Lacosamide—CA9—Cellular response to hypoxia—VEGFA—colon cancer	0.00153	0.00263	CbGpPWpGaD
Lacosamide—Liver function test abnormal—Capecitabine—colon cancer	0.00152	0.00489	CcSEcCtD
Lacosamide—CA14—Metabolism—CA7—colon cancer	0.00149	0.00257	CbGpPWpGaD
Lacosamide—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00149	0.00477	CcSEcCtD
Lacosamide—Flatulence—Irinotecan—colon cancer	0.00146	0.0047	CcSEcCtD
Lacosamide—CA6—Metabolism—CA7—colon cancer	0.00146	0.0025	CbGpPWpGaD
Lacosamide—Muscle spasms—Irinotecan—colon cancer	0.00143	0.00458	CcSEcCtD
Lacosamide—Erythema—Fluorouracil—colon cancer	0.00142	0.00456	CcSEcCtD
Lacosamide—Anaemia—Vincristine—colon cancer	0.00141	0.00452	CcSEcCtD
Lacosamide—CA3—Metabolism—ODC1—colon cancer	0.00141	0.00241	CbGpPWpGaD
Lacosamide—CA3—Metabolism—CHST5—colon cancer	0.00141	0.00241	CbGpPWpGaD
Lacosamide—Agitation—Vincristine—colon cancer	0.0014	0.0045	CcSEcCtD
Lacosamide—Anaemia—Irinotecan—colon cancer	0.00137	0.0044	CcSEcCtD
Lacosamide—Vertigo—Vincristine—colon cancer	0.00137	0.0044	CcSEcCtD
Lacosamide—CA5B—Metabolism—CA7—colon cancer	0.00136	0.00233	CbGpPWpGaD
Lacosamide—CA2—liver—colon cancer	0.00134	0.0127	CbGeAlD
Lacosamide—Vision blurred—Fluorouracil—colon cancer	0.00134	0.0043	CcSEcCtD
Lacosamide—Vertigo—Irinotecan—colon cancer	0.00133	0.00428	CcSEcCtD
Lacosamide—Neutropenia—Capecitabine—colon cancer	0.00133	0.00428	CcSEcCtD
Lacosamide—Syncope—Irinotecan—colon cancer	0.00133	0.00427	CcSEcCtD
Lacosamide—Anaemia—Fluorouracil—colon cancer	0.00131	0.00422	CcSEcCtD
Lacosamide—Loss of consciousness—Irinotecan—colon cancer	0.00131	0.00419	CcSEcCtD
Lacosamide—Depression—Capecitabine—colon cancer	0.00127	0.00407	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00126	0.00405	CcSEcCtD
Lacosamide—Discomfort—Irinotecan—colon cancer	0.00125	0.00401	CcSEcCtD
Lacosamide—CA4—lymph node—colon cancer	0.00124	0.0117	CbGeAlD
Lacosamide—Osteoarthritis—Methotrexate—colon cancer	0.00123	0.00394	CcSEcCtD
Lacosamide—Confusional state—Irinotecan—colon cancer	0.00122	0.00392	CcSEcCtD
Lacosamide—Nervous system disorder—Vincristine—colon cancer	0.00122	0.00392	CcSEcCtD
Lacosamide—Chest pain—Fluorouracil—colon cancer	0.00121	0.00389	CcSEcCtD
Lacosamide—Hyperhidrosis—Vincristine—colon cancer	0.0012	0.00386	CcSEcCtD
Lacosamide—Hepatobiliary disease—Capecitabine—colon cancer	0.0012	0.00386	CcSEcCtD
Lacosamide—Discomfort—Fluorouracil—colon cancer	0.0012	0.00384	CcSEcCtD
Lacosamide—Shock—Irinotecan—colon cancer	0.00119	0.00383	CcSEcCtD
Lacosamide—Nervous system disorder—Irinotecan—colon cancer	0.00119	0.00381	CcSEcCtD
Lacosamide—Agranulocytosis—Capecitabine—colon cancer	0.00119	0.00381	CcSEcCtD
Lacosamide—Irritability—Methotrexate—colon cancer	0.00117	0.00376	CcSEcCtD
Lacosamide—Hyperhidrosis—Irinotecan—colon cancer	0.00117	0.00376	CcSEcCtD
Lacosamide—Confusional state—Fluorouracil—colon cancer	0.00117	0.00376	CcSEcCtD
Lacosamide—Mood swings—Methotrexate—colon cancer	0.00116	0.00373	CcSEcCtD
Lacosamide—Bradycardia—Capecitabine—colon cancer	0.00116	0.00373	CcSEcCtD
Lacosamide—SCN9A—Axon guidance—DCC—colon cancer	0.00116	0.00199	CbGpPWpGaD
Lacosamide—Ataxia—Methotrexate—colon cancer	0.00116	0.00371	CcSEcCtD
Lacosamide—Hepatitis—Capecitabine—colon cancer	0.00114	0.00366	CcSEcCtD
Lacosamide—Nervous system disorder—Fluorouracil—colon cancer	0.00114	0.00365	CcSEcCtD
Lacosamide—Hypoaesthesia—Capecitabine—colon cancer	0.00114	0.00365	CcSEcCtD
Lacosamide—Liver function test abnormal—Methotrexate—colon cancer	0.00113	0.00364	CcSEcCtD
Lacosamide—Insomnia—Vincristine—colon cancer	0.00113	0.00361	CcSEcCtD
Lacosamide—Connective tissue disorder—Capecitabine—colon cancer	0.00112	0.0036	CcSEcCtD
Lacosamide—Paraesthesia—Vincristine—colon cancer	0.00112	0.00359	CcSEcCtD
Lacosamide—SCN3A—Axon guidance—DCC—colon cancer	0.00111	0.0019	CbGpPWpGaD
Lacosamide—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00111	0.00355	CcSEcCtD
Lacosamide—Insomnia—Irinotecan—colon cancer	0.0011	0.00352	CcSEcCtD
Lacosamide—Paraesthesia—Irinotecan—colon cancer	0.00109	0.00349	CcSEcCtD
Lacosamide—Erythema multiforme—Capecitabine—colon cancer	0.00108	0.00346	CcSEcCtD
Lacosamide—Somnolence—Irinotecan—colon cancer	0.00108	0.00346	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Vincristine—colon cancer	0.00107	0.00345	CcSEcCtD
Lacosamide—Fatigue—Vincristine—colon cancer	0.00107	0.00344	CcSEcCtD
Lacosamide—Eye disorder—Capecitabine—colon cancer	0.00107	0.00342	CcSEcCtD
Lacosamide—Dyspepsia—Irinotecan—colon cancer	0.00107	0.00342	CcSEcCtD
Lacosamide—Tinnitus—Capecitabine—colon cancer	0.00106	0.00342	CcSEcCtD
Lacosamide—Constipation—Vincristine—colon cancer	0.00106	0.00341	CcSEcCtD
Lacosamide—Cardiac disorder—Capecitabine—colon cancer	0.00106	0.0034	CcSEcCtD
Lacosamide—Eosinophilia—Methotrexate—colon cancer	0.00105	0.00337	CcSEcCtD
Lacosamide—Insomnia—Fluorouracil—colon cancer	0.00105	0.00337	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Irinotecan—colon cancer	0.00105	0.00336	CcSEcCtD
Lacosamide—Fatigue—Irinotecan—colon cancer	0.00104	0.00335	CcSEcCtD
Lacosamide—Paraesthesia—Fluorouracil—colon cancer	0.00104	0.00334	CcSEcCtD
Lacosamide—Constipation—Irinotecan—colon cancer	0.00104	0.00333	CcSEcCtD
Lacosamide—Somnolence—Fluorouracil—colon cancer	0.00103	0.00331	CcSEcCtD
Lacosamide—Immune system disorder—Capecitabine—colon cancer	0.00103	0.00331	CcSEcCtD
Lacosamide—CA2—lymph node—colon cancer	0.00103	0.00972	CbGeAlD
Lacosamide—SCN10A—Axon guidance—DCC—colon cancer	0.00103	0.00176	CbGpPWpGaD
Lacosamide—Dyspepsia—Fluorouracil—colon cancer	0.00102	0.00328	CcSEcCtD
Lacosamide—CA4—Metabolism—CA7—colon cancer	0.001	0.00172	CbGpPWpGaD
Lacosamide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.001	0.00322	CcSEcCtD
Lacosamide—Mental disorder—Capecitabine—colon cancer	0.001	0.00321	CcSEcCtD
Lacosamide—Feeling abnormal—Irinotecan—colon cancer	0.000999	0.0032	CcSEcCtD
Lacosamide—Erythema—Capecitabine—colon cancer	0.000994	0.00319	CcSEcCtD
Lacosamide—Neutropenia—Methotrexate—colon cancer	0.000993	0.00319	CcSEcCtD
Lacosamide—Body temperature increased—Vincristine—colon cancer	0.000984	0.00316	CcSEcCtD
Lacosamide—Flatulence—Capecitabine—colon cancer	0.000979	0.00314	CcSEcCtD
Lacosamide—CA2—Metabolism—CA7—colon cancer	0.000963	0.00165	CbGpPWpGaD
Lacosamide—Body temperature increased—Irinotecan—colon cancer	0.000958	0.00307	CcSEcCtD
Lacosamide—Feeling abnormal—Fluorouracil—colon cancer	0.000957	0.00307	CcSEcCtD
Lacosamide—Muscle spasms—Capecitabine—colon cancer	0.000956	0.00307	CcSEcCtD
Lacosamide—Depression—Methotrexate—colon cancer	0.000944	0.00303	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000939	0.00301	CcSEcCtD
Lacosamide—Vision blurred—Capecitabine—colon cancer	0.000937	0.00301	CcSEcCtD
Lacosamide—Tremor—Capecitabine—colon cancer	0.000931	0.00299	CcSEcCtD
Lacosamide—CA1—Metabolism—CA7—colon cancer	0.000924	0.00159	CbGpPWpGaD
Lacosamide—Urticaria—Fluorouracil—colon cancer	0.000922	0.00296	CcSEcCtD
Lacosamide—Anaemia—Capecitabine—colon cancer	0.000919	0.00295	CcSEcCtD
Lacosamide—Body temperature increased—Fluorouracil—colon cancer	0.000918	0.00294	CcSEcCtD
Lacosamide—Hypersensitivity—Vincristine—colon cancer	0.000917	0.00294	CcSEcCtD
Lacosamide—CA14—Metabolism—CHST5—colon cancer	0.000906	0.00155	CbGpPWpGaD
Lacosamide—CA14—Metabolism—ODC1—colon cancer	0.000906	0.00155	CbGpPWpGaD
Lacosamide—Hepatobiliary disease—Methotrexate—colon cancer	0.000895	0.00287	CcSEcCtD
Lacosamide—Vertigo—Capecitabine—colon cancer	0.000893	0.00287	CcSEcCtD
Lacosamide—Hypersensitivity—Irinotecan—colon cancer	0.000893	0.00287	CcSEcCtD
Lacosamide—Asthenia—Vincristine—colon cancer	0.000893	0.00287	CcSEcCtD
Lacosamide—Syncope—Capecitabine—colon cancer	0.000891	0.00286	CcSEcCtD
Lacosamide—Agranulocytosis—Methotrexate—colon cancer	0.000884	0.00284	CcSEcCtD
Lacosamide—CA6—Metabolism—ODC1—colon cancer	0.000883	0.00152	CbGpPWpGaD
Lacosamide—CA6—Metabolism—CHST5—colon cancer	0.000883	0.00152	CbGpPWpGaD
Lacosamide—Palpitations—Capecitabine—colon cancer	0.000878	0.00282	CcSEcCtD
Lacosamide—Loss of consciousness—Capecitabine—colon cancer	0.000874	0.0028	CcSEcCtD
Lacosamide—Asthenia—Irinotecan—colon cancer	0.00087	0.00279	CcSEcCtD
Lacosamide—Hypersensitivity—Fluorouracil—colon cancer	0.000855	0.00274	CcSEcCtD
Lacosamide—Diarrhoea—Vincristine—colon cancer	0.000852	0.00273	CcSEcCtD
Lacosamide—Hepatitis—Methotrexate—colon cancer	0.00085	0.00273	CcSEcCtD
Lacosamide—Chest pain—Capecitabine—colon cancer	0.000846	0.00272	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00084	0.0027	CcSEcCtD
Lacosamide—CA1—C-MYB transcription factor network—PTGS2—colon cancer	0.00084	0.00144	CbGpPWpGaD
Lacosamide—Discomfort—Capecitabine—colon cancer	0.000836	0.00268	CcSEcCtD
Lacosamide—Diarrhoea—Irinotecan—colon cancer	0.000829	0.00266	CcSEcCtD
Lacosamide—Dry mouth—Capecitabine—colon cancer	0.000828	0.00266	CcSEcCtD
Lacosamide—SCN9A—Developmental Biology—DCC—colon cancer	0.000826	0.00142	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—CHST5—colon cancer	0.000824	0.00141	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—ODC1—colon cancer	0.000824	0.00141	CbGpPWpGaD
Lacosamide—Dizziness—Vincristine—colon cancer	0.000823	0.00264	CcSEcCtD
Lacosamide—Pruritus—Fluorouracil—colon cancer	0.000821	0.00264	CcSEcCtD
Lacosamide—Confusional state—Capecitabine—colon cancer	0.000818	0.00262	CcSEcCtD
Lacosamide—CA9—Metabolism—CA7—colon cancer	0.000812	0.00139	CbGpPWpGaD
Lacosamide—Erythema multiforme—Methotrexate—colon cancer	0.000804	0.00258	CcSEcCtD
Lacosamide—Dizziness—Irinotecan—colon cancer	0.000801	0.00257	CcSEcCtD
Lacosamide—Shock—Capecitabine—colon cancer	0.000798	0.00256	CcSEcCtD
Lacosamide—Nervous system disorder—Capecitabine—colon cancer	0.000796	0.00255	CcSEcCtD
Lacosamide—Eye disorder—Methotrexate—colon cancer	0.000794	0.00255	CcSEcCtD
Lacosamide—Diarrhoea—Fluorouracil—colon cancer	0.000794	0.00255	CcSEcCtD
Lacosamide—Tinnitus—Methotrexate—colon cancer	0.000792	0.00254	CcSEcCtD
Lacosamide—Vomiting—Vincristine—colon cancer	0.000791	0.00254	CcSEcCtD
Lacosamide—SCN3A—Developmental Biology—DCC—colon cancer	0.00079	0.00136	CbGpPWpGaD
Lacosamide—Cardiac disorder—Methotrexate—colon cancer	0.000789	0.00253	CcSEcCtD
Lacosamide—Skin disorder—Capecitabine—colon cancer	0.000788	0.00253	CcSEcCtD
Lacosamide—Rash—Vincristine—colon cancer	0.000785	0.00252	CcSEcCtD
Lacosamide—Hyperhidrosis—Capecitabine—colon cancer	0.000784	0.00252	CcSEcCtD
Lacosamide—Dermatitis—Vincristine—colon cancer	0.000784	0.00252	CcSEcCtD
Lacosamide—Headache—Vincristine—colon cancer	0.00078	0.0025	CcSEcCtD
Lacosamide—Vomiting—Irinotecan—colon cancer	0.000771	0.00247	CcSEcCtD
Lacosamide—Immune system disorder—Methotrexate—colon cancer	0.000768	0.00246	CcSEcCtD
Lacosamide—Dizziness—Fluorouracil—colon cancer	0.000768	0.00246	CcSEcCtD
Lacosamide—Rash—Irinotecan—colon cancer	0.000764	0.00245	CcSEcCtD
Lacosamide—Dermatitis—Irinotecan—colon cancer	0.000764	0.00245	CcSEcCtD
Lacosamide—Headache—Irinotecan—colon cancer	0.000759	0.00244	CcSEcCtD
Lacosamide—CA1—C-MYB transcription factor network—CCND1—colon cancer	0.000759	0.0013	CbGpPWpGaD
Lacosamide—Mental disorder—Methotrexate—colon cancer	0.000745	0.00239	CcSEcCtD
Lacosamide—CA9—HIF-1-alpha transcription factor network—EP300—colon cancer	0.000744	0.00128	CbGpPWpGaD
Lacosamide—Erythema—Methotrexate—colon cancer	0.00074	0.00237	CcSEcCtD
Lacosamide—Nausea—Vincristine—colon cancer	0.000739	0.00237	CcSEcCtD
Lacosamide—Vomiting—Fluorouracil—colon cancer	0.000738	0.00237	CcSEcCtD
Lacosamide—CA1—C-MYB transcription factor network—CDKN1A—colon cancer	0.000734	0.00126	CbGpPWpGaD
Lacosamide—Insomnia—Capecitabine—colon cancer	0.000734	0.00235	CcSEcCtD
Lacosamide—Rash—Fluorouracil—colon cancer	0.000732	0.00235	CcSEcCtD
Lacosamide—SCN10A—Developmental Biology—DCC—colon cancer	0.000732	0.00126	CbGpPWpGaD
Lacosamide—Dermatitis—Fluorouracil—colon cancer	0.000731	0.00235	CcSEcCtD
Lacosamide—Paraesthesia—Capecitabine—colon cancer	0.000728	0.00234	CcSEcCtD
Lacosamide—Headache—Fluorouracil—colon cancer	0.000727	0.00233	CcSEcCtD
Lacosamide—Nausea—Irinotecan—colon cancer	0.00072	0.00231	CcSEcCtD
Lacosamide—Dyspepsia—Capecitabine—colon cancer	0.000714	0.00229	CcSEcCtD
Lacosamide—SCN9A—L1CAM interactions—SRC—colon cancer	0.000712	0.00122	CbGpPWpGaD
Lacosamide—CA9—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.000705	0.00121	CbGpPWpGaD
Lacosamide—Gastrointestinal disorder—Capecitabine—colon cancer	0.0007	0.00225	CcSEcCtD
Lacosamide—Fatigue—Capecitabine—colon cancer	0.000699	0.00224	CcSEcCtD
Lacosamide—CA1—C-MYB transcription factor network—EP300—colon cancer	0.000698	0.0012	CbGpPWpGaD
Lacosamide—Vision blurred—Methotrexate—colon cancer	0.000697	0.00224	CcSEcCtD
Lacosamide—SCN9A—Developmental Biology—HNF4A—colon cancer	0.000695	0.00119	CbGpPWpGaD
Lacosamide—Constipation—Capecitabine—colon cancer	0.000694	0.00223	CcSEcCtD
Lacosamide—Nausea—Fluorouracil—colon cancer	0.00069	0.00221	CcSEcCtD
Lacosamide—Anaemia—Methotrexate—colon cancer	0.000684	0.00219	CcSEcCtD
Lacosamide—SCN3A—L1CAM interactions—SRC—colon cancer	0.000681	0.00117	CbGpPWpGaD
Lacosamide—Feeling abnormal—Capecitabine—colon cancer	0.000668	0.00214	CcSEcCtD
Lacosamide—SCN3A—Developmental Biology—HNF4A—colon cancer	0.000665	0.00114	CbGpPWpGaD
Lacosamide—Vertigo—Methotrexate—colon cancer	0.000665	0.00213	CcSEcCtD
Lacosamide—CA1—C-MYB transcription factor network—NRAS—colon cancer	0.000653	0.00112	CbGpPWpGaD
Lacosamide—Urticaria—Capecitabine—colon cancer	0.000644	0.00207	CcSEcCtD
Lacosamide—Body temperature increased—Capecitabine—colon cancer	0.000641	0.00206	CcSEcCtD
Lacosamide—SCN10A—L1CAM interactions—SRC—colon cancer	0.000631	0.00108	CbGpPWpGaD
Lacosamide—Chest pain—Methotrexate—colon cancer	0.00063	0.00202	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000626	0.00201	CcSEcCtD
Lacosamide—SCN9A—L1CAM interactions—EGFR—colon cancer	0.000624	0.00107	CbGpPWpGaD
Lacosamide—Discomfort—Methotrexate—colon cancer	0.000622	0.002	CcSEcCtD
Lacosamide—SCN10A—Developmental Biology—HNF4A—colon cancer	0.000616	0.00106	CbGpPWpGaD
Lacosamide—Confusional state—Methotrexate—colon cancer	0.000609	0.00195	CcSEcCtD
Lacosamide—CA4—Metabolism—ODC1—colon cancer	0.000609	0.00104	CbGpPWpGaD
Lacosamide—CA4—Metabolism—CHST5—colon cancer	0.000609	0.00104	CbGpPWpGaD
Lacosamide—CA1—C-MYB transcription factor network—MYC—colon cancer	0.000608	0.00104	CbGpPWpGaD
Lacosamide—Hypersensitivity—Capecitabine—colon cancer	0.000598	0.00192	CcSEcCtD
Lacosamide—SCN3A—L1CAM interactions—EGFR—colon cancer	0.000597	0.00102	CbGpPWpGaD
Lacosamide—Nervous system disorder—Methotrexate—colon cancer	0.000592	0.0019	CcSEcCtD
Lacosamide—Skin disorder—Methotrexate—colon cancer	0.000587	0.00188	CcSEcCtD
Lacosamide—Hyperhidrosis—Methotrexate—colon cancer	0.000584	0.00187	CcSEcCtD
Lacosamide—CA2—Metabolism—CHST5—colon cancer	0.000584	0.001	CbGpPWpGaD
Lacosamide—CA2—Metabolism—ODC1—colon cancer	0.000584	0.001	CbGpPWpGaD
Lacosamide—Asthenia—Capecitabine—colon cancer	0.000582	0.00187	CcSEcCtD
Lacosamide—Pruritus—Capecitabine—colon cancer	0.000574	0.00184	CcSEcCtD
Lacosamide—CA1—C-MYB transcription factor network—KRAS—colon cancer	0.000562	0.000965	CbGpPWpGaD
Lacosamide—CA1—Metabolism—CHST5—colon cancer	0.00056	0.00096	CbGpPWpGaD
Lacosamide—CA1—Metabolism—ODC1—colon cancer	0.00056	0.00096	CbGpPWpGaD
Lacosamide—Diarrhoea—Capecitabine—colon cancer	0.000555	0.00178	CcSEcCtD
Lacosamide—SCN10A—L1CAM interactions—EGFR—colon cancer	0.000553	0.000949	CbGpPWpGaD
Lacosamide—Insomnia—Methotrexate—colon cancer	0.000546	0.00175	CcSEcCtD
Lacosamide—Paraesthesia—Methotrexate—colon cancer	0.000542	0.00174	CcSEcCtD
Lacosamide—Somnolence—Methotrexate—colon cancer	0.000537	0.00172	CcSEcCtD
Lacosamide—Dizziness—Capecitabine—colon cancer	0.000536	0.00172	CcSEcCtD
Lacosamide—Dyspepsia—Methotrexate—colon cancer	0.000532	0.00171	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Methotrexate—colon cancer	0.000521	0.00167	CcSEcCtD
Lacosamide—Fatigue—Methotrexate—colon cancer	0.000521	0.00167	CcSEcCtD
Lacosamide—Vomiting—Capecitabine—colon cancer	0.000516	0.00165	CcSEcCtD
Lacosamide—Rash—Capecitabine—colon cancer	0.000511	0.00164	CcSEcCtD
Lacosamide—Dermatitis—Capecitabine—colon cancer	0.000511	0.00164	CcSEcCtD
Lacosamide—Headache—Capecitabine—colon cancer	0.000508	0.00163	CcSEcCtD
Lacosamide—Feeling abnormal—Methotrexate—colon cancer	0.000498	0.0016	CcSEcCtD
Lacosamide—CA9—Metabolism—ODC1—colon cancer	0.000492	0.000844	CbGpPWpGaD
Lacosamide—CA9—Metabolism—CHST5—colon cancer	0.000492	0.000844	CbGpPWpGaD
Lacosamide—Nausea—Capecitabine—colon cancer	0.000482	0.00155	CcSEcCtD
Lacosamide—Urticaria—Methotrexate—colon cancer	0.00048	0.00154	CcSEcCtD
Lacosamide—CA1—C-MYB transcription factor network—HRAS—colon cancer	0.000478	0.00082	CbGpPWpGaD
Lacosamide—Body temperature increased—Methotrexate—colon cancer	0.000477	0.00153	CcSEcCtD
Lacosamide—CA9—HIF-1-alpha transcription factor network—AKT1—colon cancer	0.00045	0.000772	CbGpPWpGaD
Lacosamide—Hypersensitivity—Methotrexate—colon cancer	0.000445	0.00143	CcSEcCtD
Lacosamide—Asthenia—Methotrexate—colon cancer	0.000433	0.00139	CcSEcCtD
Lacosamide—Pruritus—Methotrexate—colon cancer	0.000427	0.00137	CcSEcCtD
Lacosamide—Diarrhoea—Methotrexate—colon cancer	0.000413	0.00133	CcSEcCtD
Lacosamide—Dizziness—Methotrexate—colon cancer	0.000399	0.00128	CcSEcCtD
Lacosamide—Vomiting—Methotrexate—colon cancer	0.000384	0.00123	CcSEcCtD
Lacosamide—Rash—Methotrexate—colon cancer	0.000381	0.00122	CcSEcCtD
Lacosamide—Dermatitis—Methotrexate—colon cancer	0.00038	0.00122	CcSEcCtD
Lacosamide—Headache—Methotrexate—colon cancer	0.000378	0.00121	CcSEcCtD
Lacosamide—CA3—Metabolism—ABCB1—colon cancer	0.000371	0.000638	CbGpPWpGaD
Lacosamide—CA3—Metabolism—TYMS—colon cancer	0.000365	0.000626	CbGpPWpGaD
Lacosamide—Nausea—Methotrexate—colon cancer	0.000359	0.00115	CcSEcCtD
Lacosamide—SCN9A—Developmental Biology—PPARG—colon cancer	0.000302	0.000518	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—PPARG—colon cancer	0.000289	0.000495	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—SRC—colon cancer	0.000269	0.000462	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—PPARG—colon cancer	0.000267	0.000459	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—VEGFA—colon cancer	0.000262	0.00045	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—NRAS—colon cancer	0.000259	0.000444	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PPARG—colon cancer	0.000258	0.000444	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—CDKN1A—colon cancer	0.000258	0.000443	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—SRC—colon cancer	0.000257	0.000442	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—VEGFA—colon cancer	0.000251	0.00043	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—NRAS—colon cancer	0.000248	0.000425	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—EP300—colon cancer	0.000246	0.000422	CbGpPWpGaD
Lacosamide—CA14—Metabolism—ABCB1—colon cancer	0.000239	0.000411	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—SRC—colon cancer	0.000238	0.000409	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—EGFR—colon cancer	0.000236	0.000405	CbGpPWpGaD
Lacosamide—CA14—Metabolism—TYMS—colon cancer	0.000235	0.000403	CbGpPWpGaD
Lacosamide—CA6—Metabolism—ABCB1—colon cancer	0.000233	0.0004	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—VEGFA—colon cancer	0.000233	0.000399	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—VEGFA—colon cancer	0.000232	0.000399	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—NRAS—colon cancer	0.000229	0.000394	CbGpPWpGaD
Lacosamide—CA6—Metabolism—TYMS—colon cancer	0.000229	0.000393	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—EGFR—colon cancer	0.000226	0.000387	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—KRAS—colon cancer	0.000223	0.000382	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—ABCB1—colon cancer	0.000218	0.000374	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—TYMS—colon cancer	0.000214	0.000367	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—KRAS—colon cancer	0.000213	0.000366	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—CTNNB1—colon cancer	0.000212	0.000365	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—EGFR—colon cancer	0.000209	0.000359	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PTGS2—colon cancer	0.000203	0.000349	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—CTNNB1—colon cancer	0.000203	0.000349	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—EP300—colon cancer	0.000197	0.000339	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—KRAS—colon cancer	0.000197	0.000339	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—SRC—colon cancer	0.000192	0.00033	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—HRAS—colon cancer	0.000189	0.000325	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—EP300—colon cancer	0.000189	0.000324	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—CTNNB1—colon cancer	0.000188	0.000323	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—VEGFA—colon cancer	0.000187	0.000321	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—NRAS—colon cancer	0.000185	0.000317	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—SRC—colon cancer	0.000184	0.000315	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—HRAS—colon cancer	0.000181	0.000311	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—VEGFA—colon cancer	0.000179	0.000307	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—NRAS—colon cancer	0.000177	0.000303	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—TP53—colon cancer	0.000176	0.000302	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—EP300—colon cancer	0.000175	0.0003	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—TGFB1—colon cancer	0.000172	0.000295	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—SRC—colon cancer	0.00017	0.000292	CbGpPWpGaD
Lacosamide—CA3—Metabolism—EP300—colon cancer	0.000169	0.00029	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—EGFR—colon cancer	0.000168	0.000289	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—HRAS—colon cancer	0.000168	0.000288	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PPARG—colon cancer	0.000167	0.000286	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—VEGFA—colon cancer	0.000166	0.000284	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—TGFB1—colon cancer	0.000164	0.000282	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—NRAS—colon cancer	0.000164	0.000281	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PPARG—colon cancer	0.000162	0.000279	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—EGFR—colon cancer	0.000161	0.000276	CbGpPWpGaD
Lacosamide—CA4—Metabolism—ABCB1—colon cancer	0.000161	0.000276	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—KRAS—colon cancer	0.000159	0.000273	CbGpPWpGaD
Lacosamide—CA4—Metabolism—TYMS—colon cancer	0.000158	0.000271	CbGpPWpGaD
Lacosamide—CA2—Metabolism—ABCB1—colon cancer	0.000154	0.000265	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—TGFB1—colon cancer	0.000152	0.000261	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—KRAS—colon cancer	0.000152	0.000261	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PPARG—colon cancer	0.000151	0.00026	CbGpPWpGaD
Lacosamide—CA2—Metabolism—TYMS—colon cancer	0.000151	0.00026	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—EGFR—colon cancer	0.000149	0.000256	CbGpPWpGaD
Lacosamide—CA1—Metabolism—ABCB1—colon cancer	0.000148	0.000254	CbGpPWpGaD
Lacosamide—CA1—Metabolism—TYMS—colon cancer	0.000145	0.000249	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—KRAS—colon cancer	0.000141	0.000242	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—HRAS—colon cancer	0.000135	0.000232	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PTGS2—colon cancer	0.000131	0.000225	CbGpPWpGaD
Lacosamide—CA9—Metabolism—ABCB1—colon cancer	0.00013	0.000223	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—HRAS—colon cancer	0.000129	0.000222	CbGpPWpGaD
Lacosamide—CA9—Metabolism—TYMS—colon cancer	0.000128	0.000219	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PTGS2—colon cancer	0.000128	0.000219	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PIK3CA—colon cancer	0.000125	0.000215	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—HRAS—colon cancer	0.00012	0.000206	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—AKT1—colon cancer	0.000119	0.000205	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PTGS2—colon cancer	0.000119	0.000205	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—AKT1—colon cancer	0.000114	0.000196	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PPARG—colon cancer	0.000112	0.000192	CbGpPWpGaD
Lacosamide—CA14—Metabolism—EP300—colon cancer	0.000109	0.000187	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PPARG—colon cancer	0.000107	0.000184	CbGpPWpGaD
Lacosamide—CA6—Metabolism—EP300—colon cancer	0.000106	0.000182	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—AKT1—colon cancer	0.000106	0.000181	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PPARG—colon cancer	0.000103	0.000177	CbGpPWpGaD
Lacosamide—CA3—Metabolism—AKT1—colon cancer	0.000102	0.000175	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—EP300—colon cancer	9.91e-05	0.00017	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PPARG—colon cancer	9.04e-05	0.000155	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PTGS2—colon cancer	8.8e-05	0.000151	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PTGS2—colon cancer	8.44e-05	0.000145	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PTGS2—colon cancer	8.09e-05	0.000139	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PIK3CA—colon cancer	8.06e-05	0.000138	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PIK3CA—colon cancer	7.85e-05	0.000135	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PIK3CA—colon cancer	7.33e-05	0.000126	CbGpPWpGaD
Lacosamide—CA4—Metabolism—EP300—colon cancer	7.32e-05	0.000126	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PTGS2—colon cancer	7.11e-05	0.000122	CbGpPWpGaD
Lacosamide—CA2—Metabolism—EP300—colon cancer	7.02e-05	0.000121	CbGpPWpGaD
Lacosamide—CA1—Metabolism—EP300—colon cancer	6.73e-05	0.000116	CbGpPWpGaD
Lacosamide—CA14—Metabolism—AKT1—colon cancer	6.58e-05	0.000113	CbGpPWpGaD
Lacosamide—CA6—Metabolism—AKT1—colon cancer	6.42e-05	0.00011	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—AKT1—colon cancer	5.99e-05	0.000103	CbGpPWpGaD
Lacosamide—CA9—Metabolism—EP300—colon cancer	5.92e-05	0.000102	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PIK3CA—colon cancer	5.42e-05	9.3e-05	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PIK3CA—colon cancer	5.19e-05	8.91e-05	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PIK3CA—colon cancer	4.98e-05	8.55e-05	CbGpPWpGaD
Lacosamide—CA4—Metabolism—AKT1—colon cancer	4.42e-05	7.6e-05	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PIK3CA—colon cancer	4.38e-05	7.51e-05	CbGpPWpGaD
Lacosamide—CA2—Metabolism—AKT1—colon cancer	4.24e-05	7.28e-05	CbGpPWpGaD
Lacosamide—CA1—Metabolism—AKT1—colon cancer	4.07e-05	6.98e-05	CbGpPWpGaD
Lacosamide—CA9—Metabolism—AKT1—colon cancer	3.58e-05	6.14e-05	CbGpPWpGaD
